Bluebird Spins Off Oncology Business As Cell, Gene Therapy Segments Grow Apart

Gene Therapy Focus Opens Partnering, Acquisition Opportunities

Cancer
Bluebird will spin off its oncology business into a new company. • Source: Shutterstock

More from Business

More from Scrip